Coverage
-
February 07, 2023
Groups representing the domestic pharmaceutical industry lost their suit against a federal policy allowing states and tribes to import cheaper Canadian drugs, after a D.C. federal judge ruled the groups can't claim harm when no imports have been cleared yet.
1 other articles on this case.
View all »